XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper.
Reads0
Chats0
TLDR
Details on surgical steps and tips for enhancing outcomes for an open conjunctiva technique for the implantation of the Xen Gel Stent are provided, as well as reasoning as to when this approach should be used.Abstract:
The Xen Gel Stent lowers intraocular pressure by shunting aqueous humor to the subconjunctival space. While published studies include both open conjunctiva and closed conjunctiva approaches, most publications feature a closed conjunctiva, ab interno approach. While this approach is widely used, other approaches may be preferred for some patients. This paper provides details on surgical steps and tips for enhancing outcomes for an open conjunctiva technique for the implantation of the Xen Gel Stent, as well as reasoning as to when this approach should be used.read more
Citations
More filters
Journal ArticleDOI
Comparison of Safety and Efficacy Between Ab Interno and Ab Externo Approaches to XEN Gel Stent Placement.
Nicholas E Tan,Nathaniel Tracer,Anthony Terraciano,Hardik A. Parikh,Joseph F. Panarelli,Nathan M. Radcliffe +5 more
TL;DR: In this paper, the safety and efficacy of two different techniques for implantation of the XEN Gel Stent, a minimally invasive surgical device for the treatment of refractory glaucoma, were compared.
Journal ArticleDOI
Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multicentre study.
Herbert A. Reitsamer,Vanessa I. Vera,Simon Ruben,Leon Au,Leon Au,Jorge Vila-Arteaga,Miguel A. Teus,Markus Lenzhofer,Andrew Shirlaw,Zhanying Bai,Mini Balaram,Ingeborg Stalmans +11 more
TL;DR: In this article, a multicentre, retrospective chart review of consecutive patients with open-angle glaucoma who underwent ab-interno gel stent placement alone or combined with phaco-emulsification between 1 January 2014 and 1 October 2015 was conducted.
Journal ArticleDOI
Microinvasive Glaucoma Surgery: An Evidence-Based Review.
TL;DR: In this paper, a review focusing on peer-reviewed evidence for Trabectome, iStent inject, Kahook Dual Blade, XEN® Gel Stent, and Hydrus® is presented.
Journal ArticleDOI
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications during a Long-Term Follow-Up.
Katarzyna Lewczuk,Joanna Konopińska,Joanna Jabłońska,Jacek Rudowicz,Patrycja Laszewicz,Zofia Mariak,Marek Rękas +6 more
TL;DR: In this article, the surgical and refractive outcomes of XEN glaucoma implant (Allergan, an Abbvie company, Irvine, CA, USA), a minimally invasive surgical device for the treatment of operated uncontrolled glauca, were retrospectively investigated.
Journal ArticleDOI
XEN Glaucoma Implant for the Management of Glaucoma in Naïve Patients versus Patients with Previous Glaucoma Surgery
Katarzyna Lewczuk,Joanna Konopińska,Joanna Jabłońska,Jacek Rudowicz,Patrycja Laszewicz,Diana Anna Dmuchowska,Zofia Mariak,Marek Rękas +7 more
TL;DR: In this article, the surgical and refractive outcomes of a XEN Gel Implant (Allergan, Abbvie Company, Irvine, CA, USA) in naive patients versus those with previous glaucoma surgery were analyzed.
References
More filters
Journal ArticleDOI
Wound healing in glaucoma filtering surgery.
TL;DR: The process of wound healing after glaucoma filtering surgery is summarized and the scientific rationale of several surgical and pharmacologic techniques introduced to enhance success in eyes with poor surgical prognoses is elucidated.
Journal ArticleDOI
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Matthew B. Schlenker,Husayn Gulamhusein,Ina Conrad-Hengerer,Alix Somers,Markus Lenzhofer,Ingeborg Stalmans,Herbert A. Reitsamer,Fritz H. Hengerer,Iqbal Ike K. Ahmed +8 more
TL;DR: There was no detectable difference in risk of failure and safety profiles between standalone ab interno microstent with M MC and trabeculectomy with MMC.
Journal ArticleDOI
Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months.
Davinder S. Grover,William J. Flynn,Kent P. Bashford,Richard A. Lewis,Yi Jing Duh,Rupali S. Nangia,Barbara Niksch +6 more
TL;DR: The gelatin stent reduced IOP and medication use without raising unexpected safety concerns, offering a minimally invasive surgical option for refractory glaucoma patients.
Journal ArticleDOI
Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent
TL;DR: This study demonstrated that the smaller diameter XEN 45 gel implant is statistically effective in reducing intraocular pressure and medications in glaucoma patients with a low rate of complications.
Journal ArticleDOI
Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results.
Kaweh Mansouri,Jacopo Guidotti,Harsha L. Rao,Adel Ouabas,Elisa D’Alessandro,Sylvain Roy,André Mermoud +6 more
TL;DR: The XEN gel implant as a standalone procedure or combined with cataract surgery demonstrated safe and sustained IOP reduction after 1 year, and in all, 37% of patients required needling intervention.
Related Papers (3)
Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma.
Herbert A. Reitsamer,Chelvin C A Sng,Vanessa I. Vera,Markus Lenzhofer,Keith Barton,Keith Barton,Ingeborg Stalmans,E. Ansari,Leon Au,H. B. Dick,L. Cadarso,Antonio Maria Fea,Fritz H. Hengerer,Helmut Höh,Cosme Lavin-Dapena,Kin Sheng Lim,G. Marchini,I. Masood,Georg Mossböck,M. Nagar,Marco Nardi,Marek Rękas,Tarek Shaarawy,Miguel A. Teus,Clemens Vass +24 more